Race and Sex Differences in Response to Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension

BACKGROUND: Recently studied therapies for pulmonary arterial hypertension (PAH) have improved outcomes among populations of patients, but little is known about which patients are most likely to respond to specific treatments. Differences in endothelin-1 biology between sexes and between whites and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Chest
Hlavní autoři: Gabler, Nicole B., French, Benjamin, Strom, Brian L., Liu, Ziyue, Palevsky, Harold I., Taichman, Darren B., Kawut, Steven M., Halpern, Scott D.
Médium: Artigo
Jazyk:Inglês
Vydáno: American College of Chest Physicians 2012
Témata:
Pulmonary Vascular Disease
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5991545/
https://ncbi.nlm.nih.gov/pubmed/21940766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.11-0404
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky